Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
SAGA raises 40 million SEK (€3.7 million) to advance ultrasensitive cancer liquid biopsies
Finance

SAGA raises 40 million SEK (€3.7 million) to advance ultrasensitive cancer liquid biopsies

SmiLe Incubator
June 13, 2019

‍SAGA Diagnostics AB today announces the raising of SEK 40 million in venture-backed financing (circa EUR 3.7 million, USD 4.1 million).

Ultimovacs enter the Oslo Stock Exchange
Finance

Ultimovacs enter the Oslo Stock Exchange

Oslo Cancer Cluster
June 7, 2019

Oslo Cancer Cluster member Ultimovacs have raised NOK 370 million and entered the Oslo Stock Exchange

Gedea Biotech receives Vinnova grant
Finance

Gedea Biotech receives Vinnova grant

SmiLe Incubator
May 28, 2019

Gedea has been awarded SEK 3 million in the call for proposals from SWELIFE and Medtech4Health for Collaboration for better health 2019

Life science company wins biggest order in its history
Finance

Life science company wins biggest order in its history

Umeå Biotech Incubator
April 29, 2019

Umeå-based life science company Inficure Bio has just won the largest contract in its history.

Umeå life science company granted millions to develop new product
Finance

Umeå life science company granted millions to develop new product

Umeå Biotech Incubator
April 5, 2019

Life science company Inficure Bio has been awarded millions by Vinnova to support the company's development of a model that will help create new treatments for fibrosis.

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018
Finance

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2018

InDex Pharmaceuticals
April 4, 2019

April 2, 2019 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2018, which is earlier than indicated in the financial calendar. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com.

Date
Title
Author
February 25, 2019
MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm
Medicon Valley Alliance
February 21, 2019
InDex Pharmaceuticals Holding AB (publ) year end report 2018
InDex Pharmaceuticals
February 4, 2019
Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
Novo Nordisk Pharmatech A/S
January 31, 2019
Ten new incubator companies and over SEK 700 million in venture capital
SmiLe Incubator
November 26, 2018
SAGA awarded SEK 4.7 million Vinnova grant from Swelife
SmiLe Incubator
November 26, 2018
Sinntaxis secures Horizon 2020 grant to prepare for phase II trial in stroke recovery
SmiLe Incubator
November 20, 2018
AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America
AbbVie
November 15, 2018
Swedish Research Council gives In2cure project SEK 950,000 and highest grades
SmiLe Incubator
November 7, 2018
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting
InDex Pharmaceuticals
October 25, 2018
InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million
InDex Pharmaceuticals
October 2, 2018
in2cure raises SEK 10 million
SmiLe Incubator
September 25, 2018
Curida attracts new investors
Curida AS
August 23, 2018
In need of start-up money?
Oslo Cancer Cluster
August 9, 2018
Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018
Novo Nordisk Pharmatech A/S
May 2, 2018
AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock
AbbVie
May 2, 2018
AbbVie Reports First-Quarter 2018 Financial Results
AbbVie
April 26, 2018
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017
InDex Pharmaceuticals
April 26, 2018
InDex Pharmaceuticals Holding AB – Annual Report 2017
InDex Pharmaceuticals

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019